Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 4
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 2, 2008
Efalizumab-induced severe thrombocytopenia can be resolved
Francesca Prignano, F Zanieri, S Mokhtarzadeh, T Lotti
Biologics: Targets and Therapy 2008, 2:923-927
Published Date: 5 December 2008
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
Dominic C Chow, Anne Tasaki, Jill Ono, Bruce Shiramizu, Scott A Souza
Biologics: Targets and Therapy 2008, 2:917-921
Published Date: 5 December 2008
Rituximab therapy in Greek patients with rheumatoid arthritis
Aristotelis P Tsiakalos, Nestor K Avgoustidis, Haralampos M Moutsopoulos
Biologics: Targets and Therapy 2008, 2:911-916
Published Date: 5 December 2008
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation
Yunbo Ke, R John Solaro
Biologics: Targets and Therapy 2008, 2:903-909
Published Date: 5 December 2008
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
Maristella D’Uva, Pierpaolo Di Micco, Ida Strina, Antonio Ranieri, Carlo Alviggi, et al
Biologics: Targets and Therapy 2008, 2:897-902
Published Date: 5 December 2008
Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines
Faten Merhi, Jacques Auger, Francine Rendu, Brigitte Bauvois
Biologics: Targets and Therapy 2008, 2:885-895
Published Date: 5 December 2008
Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels
Parmeet Kaur Manchanda, Anant Kumar, Raj K Sharma, Himanshu Goel, Rama Devi Mittal
Biologics: Targets and Therapy 2008, 2:875-884
Published Date: 5 December 2008
Abatacept in difficult-to-treat juvenile idiopathic arthritis
Jasmin B Kuemmerle-Deschner, SM Benseler
Biologics: Targets and Therapy 2008, 2:865-874
Published Date: 5 December 2008
The insulin-like growth factor system and its receptors: A potential novel anticancer target
Colin R. Lindsay, T R Jeffry Evans
Biologics: Targets and Therapy 2008, 2:855-864
Published Date: 5 December 2008
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation
Raj Kumar, William J Calhoun
Biologics: Targets and Therapy 2008, 2:845-854
Published Date: 5 December 2008
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Fernando C Fervenza, Roser Torra, David G Warnock
Biologics: Targets and Therapy 2008, 2:823-843
Published Date: 5 December 2008
Bevacizumab in the treatment of HER2-negative breast cancer
Vito Lorusso
Biologics: Targets and Therapy 2008, 2:813-821
Published Date: 5 December 2008
Novel microtubule-targeting agents – the epothilones
Kit L Cheng, Thomas Bradley, Daniel R Budman
Biologics: Targets and Therapy 2008, 2:789-811
Published Date: 5 December 2008
Sorafenib for the treatment of unresectable hepatocellular carcinoma
Junji Furuse
Biologics: Targets and Therapy 2008, 2:779-788
Published Date: 5 December 2008
Adalimumab for the treatment of Crohn’s disease
Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro
Biologics: Targets and Therapy 2008, 2:763-777
Published Date: 5 December 2008
Therapeutic vaccines for malignant brain tumors
Michael P Gustafson, Keith L Knutson, Allan B Dietz
Biologics: Targets and Therapy 2008, 2:753-761
Published Date: 5 December 2008
α-L-iduronidase therapy for mucopolysaccharidosis type I
Jakub Tolar, Paul J Orchard
Biologics: Targets and Therapy 2008, 2:743-751
Published Date: 5 December 2008
Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
Leigh D Church, Sinisa Savic, Michael F McDermott
Biologics: Targets and Therapy 2008, 2:733-742
Published Date: 5 December 2008
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
Masahide Matsuyama, Rikio Yoshimura
Biologics: Targets and Therapy 2008, 2:725-732
Published Date: 5 December 2008
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
David Kaminetzky, Kenneth B Hymes
Biologics: Targets and Therapy 2008, 2:717-724
Published Date: 5 December 2008
Small molecule tyrosine kinase inhibitors in pancreatic cancer
Sachin Gupta, Bassel F El-Rayes
Biologics: Targets and Therapy 2008, 2:707-715
Published Date: 5 December 2008
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies
Steven J Greco, Pranela Rameshwar
Biologics: Targets and Therapy 2008, 2:699-705
Published Date: 5 December 2008
Biological drugs targeting the immune response in the therapy of psoriasis
Saveria Pastore, Emanuela Gubinelli, Luca Leoni, Desanka Raskovic, Liudmila Korkina
Biologics: Targets and Therapy 2008, 2:687-697
Published Date: 5 December 2008
Anticomplement therapy
Prathit A Kulkarni, Vahid Afshar-Kharghan
Biologics: Targets and Therapy 2008, 2:671-685
Published Date: 5 December 2008
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
Hubert Marotte, Pierre Miossec
Biologics: Targets and Therapy 2008, 2:663-669
Published Date: 5 December 2008
Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)
Dana S Hardin
Biologics: Targets and Therapy 2008, 2:655-661
Published Date: 5 December 2008
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
E Michael Lewiecki
Biologics: Targets and Therapy 2008, 2:645-653
Published Date: 5 December 2008
Review of consensus interferon in the treatment of chronic hepatitis C
Th Witthöft
Biologics: Targets and Therapy 2008, 2:635-643
Published Date: 5 December 2008
Rituximab in the treatment of non-Hodgkin’s lymphoma
Beate Hauptrock, Georg Hess
Biologics: Targets and Therapy 2008, 2:619-633
Published Date: 5 December 2008
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
Tacjana Pressler
Biologics: Targets and Therapy 2008, 2:611-617
Published Date: 5 December 2008
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
Camillo Porta, Chiara Paglino, Luciano Mutti
Biologics: Targets and Therapy 2008, 2:601-609
Published Date: 5 December 2008
Clinical use of topical thrombin as a surgical hemostat
Wesley K Lew, Fred A Weaver
Biologics: Targets and Therapy 2008, 2:593-599
Published Date: 5 December 2008